(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

Therapeutic effect of ILIAS's anti-inflammatory exosome published in Science Advances

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 20-04-09 10:21
  • 조회 : 449회

본문


9 Apr 2020


Therapeutic effect of ILIAS's anti-inflammatory exosome published in Science Advances


a246b6a9715fd5042288eb8b7a9600f0_1594173838_3606.jpg

Recent research by ILIAS Biologics suggested a novel therapeutic option for sepsis treatment. In their recent publication in Science Advances, ILIAS demonstrated significant efficacy of an advanced exosome-based therapeutics in septic mouse model. Engineered exosomes with therapeutic proteins are being proven to rapidly reduce inflammatory response and are potentially effective in mitigating cytokine release. 

 

Press Link: https://www.exosome-rna.com/significant-protective-effect-of-engineered-exosomes-in-animal-models-of-sepsis/

개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기